PD-1 expression on tumor cells: a new target for cancer therapy

被引：0
|
作者：
Tone, Mari [1 ,2 ]
Iwahori, Kota [1 ,2 ,3 ]
机构：
[1] Osaka Univ, Grad Sch Med, Dept Resp Med & Clin Immunol, Osaka, Japan
[2] Osaka Univ, Grad Sch Med, Dept Clin Res Tumor Immunol, Osaka, Japan
[3] Osaka Univ, Grad Sch Med, Dept Clin Res Tumor Immunol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan
来源：
TRANSLATIONAL LUNG CANCER RESEARCH | 2024年 / 13卷 / 01期
关键词：
Anti programmed death-1 antibody (anti-PD-1 antibody); cancer stemness; non-small cell lung cancer (NSCLC); chemoresistance; PATHWAYS;
D O I：
10.21037/tlcr-23-683
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：186 / 189
页数：4
相关论文
共 50 条
  • [1] PD-1 as a potential target in cancer therapy
    McDermott, David F.
    Atkins, Michael B.
    CANCER MEDICINE, 2013, 2 (05): : 662 - 673
  • [2] PD-1/PD-L1 immune checkpoint: Potential target for cancer therapy
    Dermani, Fatemeh K.
    Samadi, Pouria
    Rahmani, Golebagh
    Kohlan, Alisa K.
    Najafi, Rezvan
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (02) : 1313 - 1325
  • [3] Dynamic change of PD-L1 expression on circulating tumor cells in advanced breast cancer undergoing PD-1 blockade therapy.
    Wang, Tao
    Zhou, Jinmei
    Zhang, Shaohua
    Bian, Li
    Hu, Zhiyuan
    Jiang, Zefei
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Metformin suppresses tumor immune evasion through downregulation of PD-L1 expression in cancer cells and PD-1 expression in NK cells and T cells
    Park, Su Hwan
    Lee, Jong-Ho
    CANCER RESEARCH, 2023, 83 (07)
  • [5] Dynamic change of PD-L1 expression on circulating tumor cells in advanced solid tumor patients undergoing PD-1 blockade therapy
    Yue, Chunyan
    Jiang, Yubo
    Li, Ping
    Wang, Yuehua
    Xue, Jian
    Li, Nannan
    Li, Da
    Wang, Ruina
    Dang, Yongjun
    Hu, Zhiyuan
    Yang, Yanlian
    Xu, Jianming
    ONCOIMMUNOLOGY, 2018, 7 (07):
  • [6] PD-1 blockade therapy for cancer
    Ribas, Antoni
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10)
  • [7] Inhibitors of the PD-1 Pathway in Tumor Therapy
    LaFleur, Martin W.
    Muroyama, Yuki
    Drake, Charles G.
    Sharpe, Arlene H.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (02): : 375 - 383
  • [8] Prognostic Significance of PD-1/PDL-1 Expression in Breast Cancer and Tumor Associated Immune Cells
    Li, Xin
    Leone, Jose P.
    Serdy, Kate
    Assylbekova, Binara
    Varma, Kavita R.
    Clark, Beth Z.
    Dabbs, David J.
    Bhargava, Rohit
    MODERN PATHOLOGY, 2017, 30 : 54A - 54A
  • [9] The PD-L1/PD-1 axis expression on tumor-infiltrating immune cells and tumor cells in pediatric rhabdomyosarcoma
    Gabrych, Anna
    Peksa, Rafal
    Kunc, Michal
    Krawczyk, Malgorzata
    Izycka-Swieszewska, Ewa
    Biernat, Wojciech
    Bien, Ewa
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (12)
  • [10] Tumor-derived exosomal PD-L1: a new perspective in PD-1/PD-L1 therapy for lung cancer
    Wu, Yunjiao
    Fu, Huichao
    Hao, Jingwei
    Yang, Zhaoyang
    Qiao, Xinyi
    Li, Yingjie
    Zhao, Rui
    Lin, Tie
    Wang, Yicun
    Wang, Meng
    FRONTIERS IN IMMUNOLOGY, 2024, 15
12345